Tomorrow at the Goldman Sachs Global Healthcare Conference, join Caribou’s president and CEO Rachel Haurwitz, PhD, for a fireside chat at 8:00am ET. The webcast of the presentation can be found on our website here: bit.ly/3E0bqxd #celltherapy #CRISPR $CRBU

How is Caribou working to address outstanding challenges in cancer treatment? To find out, listen to the What’s Your Problem podcast with Jacob Goldstein as he talks with our president and CEO. pushkin.fm/podcasts/whats…

Tomorrow, $CRBU chief financial officer Jason O’Byrne will participate in a panel discussion with the San Francisco CFO Leadership Council. Register for the webcast on the event website here: cfoleadershipcouncil.com/chapters/san-f… CFO Leadership Council

Today, Caribou is observing #Juneteenth – a national holiday that commemorates the emancipation of enslaved African Americans in the United States. This day of remembrance stands as a reminder of the work that still needs to be done to achieve #equality for all. #EmancipationDay

What advancements have been made to made to reduce off-targeting editing? Caribou’s CSO Steve Kanner, PhD, provides insights on this panel discussion with Cell&Gene host Erin Harris: event.on24.com/wcc/r/4567517/…

Happy Independence Day from the Caribou Biosciences team! The Herd will be taking both the 4th and 5th off to spend time with family and friends. We wish you a restful holiday.

Today we announced the appointment of Terri Laufer, MD, to our scientific advisory board. Welcome to #theHerd, Dr. Laufer! bit.ly/3S1cg42 #Lupus

“[chRDNA] technology enables us to maintain very high genome edits on-target, but we do not detect the off-targets within the limits of detection of the assay, in comparison to an all-RNA guide of the same sequence” #ASGCT2024 #CRISPR Caribou Biosciences Watch: cgtlive.com/view/kanner-ca…

Members of Caribou’s clinical team will be at the Pan Pacific Lymphoma Conference this week. Check out our poster online sharing our recently reported update on the CB-010 ANTLER Phase 1 trial. Learn more: bit.ly/3KUBZHB hashtag#PPLC24 hashtag#lymSM hashtag#oncology

We’re happy to have this incredible group of interns join #theHerd this summer! Interns are partnering with other Herd members on projects that will be presented at our annual internship symposium in August. #NationalInternDay #CRISPR #CARtcells #humanresources

We are advancing four oncology and autoimmune disease clinical-stage programs through multiple clinical data milestones expected in 2024 and 2025. Learn more about our progress in our Q2 2024 financial results here: bit.ly/4dBvWUJ $CRBU #CRISPR #CARTcelltherapy

Caribou Biosciences turns 12! Yesterday, members of #TheHerd gathered to celebrate Caribou’s birthday and reminisce on the incredible discoveries and clinical progress over the years. #HappyBirthday! #strongertogether

Motivated interns joined Caribou this summer to support our teams and provide fresh perspectives in developing #celltherapies for patients with devastating diseases. Yesterday they presented their impressive work to the herd at our annual intern symposium. #strongertogether

We’re excited to announce the appointment of Tina Albertson, MD, PhD, as Caribou’s chief medical officer. Welcome to the herd! investor.cariboubio.com/news-releases/… $CRBU

$CRBU to participate in upcoming investor conferences. bit.ly/4e2pxSJ

#WomensEqualityDay commemorates strides the U.S. has taken towards equal rights and freedoms for women. Carrying on this legacy, #diversity and #inclusion are pillars to our work, and we are proud to have women represented at every level at Caribou.

It's time to #TurnItRed for #BloodCancerAwarenessMonth! At Caribou, we’re developing allogeneic CAR-T cell therapies for patients with hematologic malignancies. Join us this September in recognizing those affected by #bloodcancer.